Healthcare

>

Major Pharmaceuticals

>

NASDAQ:
GOVXW

GeoVax Labs, Inc. - Warrants

Recent publications about $GOVXW

GeoVax Announces Issuance of Malaria Vaccine Patent

GeoVax’s Unique Multi-Antigenic Vaccine Approach Designed to Provide Stronger, Broader Protection Against Malaria Atlanta, GA, April 26, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — GeoVax Labs, Inc. (Nasdaq: GOVX), a

Register by Email

or
Already a member? Sign In